Clinical Trial Update: Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II) [Phase 2]

View source ↗

Summary

A Phase 2 trial led by Aarhus University Hospital investigating diurnal variation of exogenous peptides in relation to endogenous insulin in Type 2 diabetes; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Aarhus University Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED